![WCLC 2022 Conference Coverage](http://media.vumedi.com/thumbs/channel_logo/2022/8/1e11d80a-513e-4d37-b628-cc3988da4c0b.png.200x0_q85.png)
WCLC 2022 Conference Coverage
Playback speed
10 seconds
WCLC 2022 on the Phase II NAUTIKA1 Study of Targeted Therapies in Stage II-III NSCLC: Preliminary Data of Neoadjuvant Alectinib for ALK+ Disease
By
WCLC 2022 Conference Coverage
FEATURING
Jay Lee
By
WCLC 2022 Conference Coverage
FEATURING
Jay Lee
71 views
August 18, 2022
Login to view comments.
Click here to Login
Videos